Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.
about
An Inter-Ethnic Comparison Study of Ziprasidone Plasma Levels, Dosage and Clinical Response in Patients with Schizophrenia.Role of presynaptic phosphoprotein synapsin II in schizophrenia.Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome.
P2860
Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Evaluation of the pharmacokine ...... ophrenia and bipolar disorder.
@en
type
label
Evaluation of the pharmacokine ...... ophrenia and bipolar disorder.
@en
prefLabel
Evaluation of the pharmacokine ...... ophrenia and bipolar disorder.
@en
P2860
P1476
Evaluation of the pharmacokine ...... ophrenia and bipolar disorder.
@en
P2093
Laura Mercolini
P2860
P304
P356
10.1517/17425255.2015.991713
P407
P577
2014-12-06T00:00:00Z